about
Immunogenicity and safety of two doses of a non-adjuvanted influenza A H1N1/2009 vaccine in young autoimmune rheumatic diseases patients.Pandemic influenza immunization in primary antiphospholipid syndrome (PAPS): a trigger to thrombosis and autoantibody production?Epidemiology of human infection with the novel virus influenza A (H1N1) in the Hospital das Clínicas, São Paulo, Brazil--June-September 2009.Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice.Influenza A/H1N1 vaccination of patients with SLE: can antimalarial drugs restore diminished response under immunosuppressive therapy?TNF blockers show distinct patterns of immune response to the pandemic influenza A H1N1 vaccine in inflammatory arthritis patients.Pandemic unadjuvanted influenza A (H1N1) vaccine in dermatomyositis and polymyositis: immunogenicity independent of therapy and no harmful effect in disease.Short and long-term effects of pandemic unadjuvanted influenza A(H1N1)pdm09 vaccine on clinical manifestations and autoantibody profile in primary Sjögren's syndrome.High disease activity: an independent factor for reduced immunogenicity of the pandemic influenza a vaccine in patients with juvenile systemic lupus erythematosus.Cardiac autonomic impairment and chronotropic incompetence in fibromyalgia.Is isolated congenital heart block associated to neonatal lupus requiring pacemaker a distinct cardiac syndrome?Childhood systemic lupus erythematosus in Latin America. The GLADEL experience in 230 children.Acute physical exercise is safe in patients with primary antiphospholipid syndrome with exclusive venous thrombosis and under oral anticoagulation with warfarin.Macrophage activation syndrome: A severe and frequent manifestation of acute pancreatitis in 362 childhood-onset compared to 1830 adult-onset systemic lupus erythematosus patients.Autoimmune hemolytic anemia in systemic lupus erythematosus at diagnosis: differences between pediatric and adult patients.Outcomes of 847 childhood-onset systemic lupus erythematosus patients in three age groups.Validation of the Spanish, Portuguese and French versions of the Lupus Damage Index questionnaire: data from North and South America, Spain and PortugalAntimalarial treatment may have a time-dependent effect on lupus survival: data from a multinational Latin American inception cohort.Properties of the ribosomal P2 protein autoantigen are similar to those of foreign protein antigens.Cellular mechanism of the conduction abnormalities induced by serum from anti-Ro/SSA-positive patients in rabbit hearts.Infliximab induces increase in triglyceride levels in psoriatic arthritis patients.Decreased high-density lipoprotein cholesterol levels in polyarticular juvenile idiopathic arthritis.Circulating follicular helper-like T cells in systemic lupus erythematosus: association with disease activity.Heparin increases HLA-G levels in primary antiphospholipid syndrome.Mechanisms of dyslipoproteinemias in systemic lupus erythematosusAnti-inflammatory effects of intravenous methotrexate associated with lipid nanoemulsions on antigen-induced arthritis.IL-23/Th17 axis is not influenced by TNF-blocking agents in ankylosing spondylitis patientsLow sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy?Immunogenicity of influenza H1N1 vaccination in mixed connective tissue disease: effect of disease and therapy.Male fertility potential alteration in rheumatic diseases: a systematic reviewExercise training in childhood-onset systemic lupus erythematosus: a controlled randomized trial.Systemic lupus erythematosus and "lupus dyslipoproteinemia".Metabolic syndrome in rheumatological diseases.Immunogenicity of Anti-TNF-alpha agents in autoimmune diseases.Low bone mass in juvenile onset sclerosis systemic: the possible role for 25-hydroxyvitamin D insufficiency.Fatal rhabdomyolysis in systemic lupus erythematosus.Human papillomavirus and chlamydia trachomatis infections in rheumatoid arthritis under anti-TNF therapy: an observational study.Cutting-edge issues in autoimmune orchitis.Anti-TNF therapy for polymyalgia rheumatica: report of 99 cases and review of the literature.Exercise as a therapeutic tool to counteract inflammation and clinical symptoms in autoimmune rheumatic diseases.
P50
Q30354003-87F1530F-C921-46A5-A237-2127F92C6452Q30363962-D85CB64E-CD19-4BA2-A89D-4283864F1125Q30381787-D54F36B9-0AF7-4006-82EB-9F773159142CQ30406282-5CDF22D7-BC49-4E66-8989-5477FDE5A69AQ30412466-1B643273-EC9B-4744-950C-9F0199FB9B74Q30420493-AFECCFEC-218E-4B89-A8D2-CC65ADA4E461Q30423188-FA0F7576-E7E1-4D47-AE2C-7F372C29F084Q30426996-B0C82F04-CEDD-4E1C-BB6B-80020225DBA5Q30432642-D78570DA-0D32-48A2-BAAE-23887CE6D848Q30468275-BF5633E0-2DE7-4295-AEF0-FA61183F8BB0Q33151341-820C7406-0372-4B72-A4FE-55E3566AAC31Q33379920-0631EA8E-0D8F-40E2-A5E0-C25FEB6E5F9BQ33415287-51BBE70D-FDB1-4235-882C-5006F7DC4F3AQ33429692-AE2FACF1-CC49-40B4-8D29-F783084C2C69Q33436595-59DFD310-CD02-4E2B-A6C4-E6F16C3DB4B9Q33438808-57CC0566-D651-4AA5-8468-59A93E95121EQ33504486-5F3BA9D6-8DAC-41CB-A299-EF0DC8CCE0F4Q33529416-F8ABCA27-E20B-409C-931F-2CD567301768Q33632578-3586D04C-7B4E-44AD-8FD6-44D34D19303AQ34126026-7A14F96E-B1AC-4637-994B-FF81282BDE0CQ35127601-29273DB0-3521-450F-A8F3-89874C8F5EEDQ35188363-E3067A47-1B74-4287-BA24-654C325CAB4EQ35668403-B269A49C-079A-4458-8E9D-781C9BC1C249Q35986350-0EC88301-42E0-44BE-9801-D2733DB10375Q36502252-2A9E5C1A-69EC-45C9-A9D2-4247DCE2569CQ36518939-1AED8CE8-C698-4B10-89DE-E8EC8AFB1B40Q36611562-55D1C47C-1F2A-43A4-8B05-DE51450AABF2Q36633205-A76E9377-E364-4DE1-AA20-56CB88BD54C7Q36644797-1E4A0025-EE25-4F31-8BC8-767E5006D9A2Q36738110-1CA7EE82-6F9A-46B0-AF2F-347ED6E43CD0Q36903145-95BEE97B-C46C-4A28-8D72-A4B9D5FA5757Q37055444-6D1E0CD7-9C59-42B3-81FF-73DA781DEFB0Q37377015-A5C602E7-C9A7-4463-98D2-B289274E28F4Q37535680-DF4E2868-CC82-400E-9CA9-09236AA1E1F9Q37718666-330623B7-D2C0-44FA-A02D-1EDE7D32C163Q37815411-7F7698AB-F1A4-4FD3-B9F7-60556361ADC7Q37843179-8BB122B6-7483-4455-AE63-53FBBA3B9B98Q37917646-AC7500B8-3264-44C5-B76C-D6AD2A0071B8Q37974841-7F7170FF-1AA4-4E80-87C8-D8841DFB7371Q38024936-FC65C98D-361A-4198-B356-211088711B00
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Eloisa Bonfa
@ast
Eloisa Bonfa
@en
Eloisa Bonfa
@es
Eloisa Bonfa
@nl
Eloisa Bonfa
@sl
type
label
Eloisa Bonfa
@ast
Eloisa Bonfa
@en
Eloisa Bonfa
@es
Eloisa Bonfa
@nl
Eloisa Bonfa
@sl
prefLabel
Eloisa Bonfa
@ast
Eloisa Bonfa
@en
Eloisa Bonfa
@es
Eloisa Bonfa
@nl
Eloisa Bonfa
@sl
P1053
B-8438-2012
P106
P21
P31
P3829
P496
0000-0002-0520-4681